In the current project, we compared expression levels of NF-κB-related lncRNAs and mRNAs, namely CEBPA, ATG5, PACER, DILC, NKILA, ADINR, DICER1-AS1, HNF1A-AS1, CHAST and H19 in the circulation of PD patients versus healthy individuals to appraise their possible application as disease markers. This evidence concerns the gene ATG5 and Parkinson disease.